West Pharmaceutical (WST) Financial Analysis & Valuation | Quarter Chart
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Produc... more
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $26.12B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Michel Lagarde |
| IPO Date | 1980-03-17 | CAGR | 7.21% |
| Employees | 10,800 | Website | www.westpharma.com |
| Div. Yield | 0.26% | Payout Ratio | 11% |
| Buy Back Yield | — | Total Yield | 0.26% |
WST chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $26.79B | P/E | 43.66 | Forward P/E | 37.17 | PEG | 2.63 |
| P/S | 7.24 | P/B | 8.13 | P/CF | 36.8 | P/FCF | 55.41 |
| Sales | $3.33B | Sales 1Y | 12.39% | Sales 3Y | 16.11% | Sales 5Y | 31.81% |
| EPS | $8.5 | EPS 1Y | 17.07% | EPS 3Y | 13.99% | EPS 5Y | 14.33% |
| Sales QoQ | 3.24% | EPS QoQ | 11.98% | Sales QoQ Avg | 3.31% | EPS QoQ Avg | 4.45% |
| Gross Margin | 36.77% | Operating Margin | 20.64% | Profit Margin | 16.98% | ROCE | 19.98% |
| ROA | 14% | ROE | 19% | Altman Z Score | 17.86 | Piotroski Score | 8 |
| Current Ratio | 2.82 | Quick Ratio | 2.12 | Cash Ratio | 0.68 | Op. CF Ratio | 0.19 |
| Debt/Equity | 0.1 | Debt/Assets | 0.08 | Lt Debt/Equity | 0.1 | Lt Debt/Cap. | 0.09 |
| Intrst Cov. | 6865 | Inventory Turnover | 4.7 | Asset Turnover | 0.82 | Receivables Turnover | 4.67 |
| Enterprise Value | $26.79B | P/E Ratio | 43.66 |
| Forward P/E | 37.17 | PEG Ratio | 2.63 |
| P/S Ratio | 7.24 | P/B Ratio | 8.13 |
| P/CF Ratio | 36.8 | P/FCF Ratio | 55.41 |
| EPS | $8.5 | EPS Growth 1Y | 17.07% |
| EPS Growth 3Y | 13.99% | EPS Growth 5Y | 14.33% |
| Revenue Growth 1Y | 12.39% | Gross Margin | 36.77% |
| Operating Margin | 20.64% | Profit Margin | 16.98% |
| ROE | 19% | ROA | 14% |
| ROCE | 19.98% | Current Ratio | 2.82 |
| Quick Ratio | 2.12 | Cash Ratio | 0.68 |
| Debt/Equity | 0.1 | Interest Coverage | 6865 |
| Altman Z Score | 17.86 | Piotroski Score | 8 |
West Pharmaceutical (WST) valuation & financials
West Pharmaceutical (WST) has a market capitalization of $26.12B and trades at a price-to-earnings ratio of 43.7. It operates in the Healthcare sector (Medical - Instruments & Supplies).
West Pharmaceutical's revenue grew +12.4% over the last year.
West Pharmaceutical's next earnings report is scheduled for October 22, 2026 (provider scheduled date); analysts estimate EPS of $2.19. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)